Literature DB >> 16282872

Lost time, absence costs, and reduced productivity output for employees with bipolar disorder.

Nathan L Kleinman1, Richard A Brook, Krithika Rajagopalan, Harold H Gardner, Truman J Brizee, James E Smeeding.   

Abstract

OBJECTIVE: We sought to evaluate the incremental health-related lost work time and at-work productivity loss for employees with bipolar disorder (BPD).
METHODS: Health-related absence and real productivity output of employees with BPD were compared with that of non-BPD and other employee cohorts from a large employer database using multivariate regression to control for cohort differences.
RESULTS: After adjusting for confounding factors, employees with BPD had significantly higher absence costs (1,219 dollars) and 11.5 additional lost days (P<0.05) per year than those without BPD. Adjusted annual productivity output was 20% lower for the BPD group (P<0.05).
CONCLUSIONS: Employees with BPD are less likely to be present for work. When present, their productivity level is similar to that of other employees, but over the course of a year, their absence rates result in significant productivity losses.

Entities:  

Mesh:

Year:  2005        PMID: 16282872     DOI: 10.1097/01.jom.0000177048.34506.fc

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  8 in total

1.  Incurring greater health care costs: risk stratification of employees with bipolar disorder.

Authors:  Richard A Brook; Krithika Rajagopalan; Nathan L Kleinman; James E Smeeding; Truman J Brizee; Harold H Gardner
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 2.  Employee health and presenteeism: a systematic review.

Authors:  Alyssa B Schultz; Dee W Edington
Journal:  J Occup Rehabil       Date:  2007-07-25

3.  Easing the burden of bipolar disorder: from urgent situations to remission.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population.

Authors:  Richard A Brook; Nathan L Kleinman; Rok Seon Choung; James E Smeeding; Nicholas J Talley
Journal:  Dig Dis Sci       Date:  2011-07-13       Impact factor: 3.199

5.  Treating bipolar disorder in the primary care setting: the role of aripiprazole.

Authors:  J Sloan Manning; Susan L McElroy
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

6.  Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination.

Authors:  Daniel J Walker; Melissa P DelBello; John Landry; Deborah N D'Souza; Holland C Detke
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2017-07-12       Impact factor: 3.033

7.  Disability and workers' compensation trends for employees with mental disorders and SUDs in the United States.

Authors:  Richard A Brook; Nathan L Kleinman; Ian A Beren
Journal:  Ment Health Clin       Date:  2021-09-24

Review 8.  Bipolar depression: trial-based insights to guide patient care.

Authors:  David E Kemp; David J Muzina; Roger S McIntyre; Joseph R Calabrese
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.